KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Common Equity (2016 - 2026)

Historic Common Equity for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to $2.2 billion.

  • Exelixis' Common Equity fell 369.32% to $2.2 billion in Q1 2026 from the same period last year, while for Jan 2026 it was $2.2 billion, marking a year-over-year decrease of 369.32%. This contributed to the annual value of $2.2 billion for FY2026, which is 369.32% down from last year.
  • According to the latest figures from Q1 2026, Exelixis' Common Equity is $2.2 billion, which was down 369.32% from $2.2 billion recorded in Q4 2025.
  • Over the past 5 years, Exelixis' Common Equity peaked at $2.6 billion during Q1 2023, and registered a low of $2.0 billion during Q3 2025.
  • Its 5-year average for Common Equity is $2.3 billion, with a median of $2.3 billion in 2023.
  • As far as peak fluctuations go, Exelixis' Common Equity soared by 2002.23% in 2022, and later crashed by 1671.64% in 2024.
  • Exelixis' Common Equity (Quarter) stood at $2.5 billion in 2022, then fell by 9.02% to $2.3 billion in 2023, then grew by 0.51% to $2.3 billion in 2024, then decreased by 5.04% to $2.2 billion in 2025, then increased by 0.03% to $2.2 billion in 2026.
  • Its last three reported values are $2.2 billion in Q1 2026, $2.2 billion for Q4 2025, and $2.0 billion during Q3 2025.